Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery.

Long GV, Garnett-Benson C, Dolfi S, Ascierto PA, Guo J, Tarhini AA, Chandra S, Muñoz-Couselo E, Del Vecchio M, de Melo AC, Callahan M, Gogas H, Dummer R, Schadendorf D, Koelblinger P, Quereux G, Thomas I, Yu JX, Fisher A, Wang B, Djidel P, Chouzy A, Semaan M, Chen B, Cheong AMY, Tawbi HA

Open source

DOI: 10.1080/14796694.2026.2721180
Published: 2026 Sep 22
Container: Future oncology (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2026.2721180,
  title = {Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery.},
  author = {Long GV and Garnett-Benson C and Dolfi S and Ascierto PA and Guo J and Tarhini AA and Chandra S and Muñoz-Couselo E and Del Vecchio M and de Melo AC and Callahan M and Gogas H and Dummer R and Schadendorf D and Koelblinger P and Quereux G and Thomas I and Yu JX and Fisher A and Wang B and Djidel P and Chouzy A and Semaan M and Chen B and Cheong AMY and Tawbi HA},
  year = {2026},
  journal = {Future oncology (London, England)},
  doi = {10.1080/14796694.2026.2721180},
  url = {https://doi.org/10.1080/14796694.2026.2721180}
}

RIS

TY  - JOUR
TI  - Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery.
AU  - Long GV
AU  - Garnett-Benson C
AU  - Dolfi S
AU  - Ascierto PA
AU  - Guo J
AU  - Tarhini AA
AU  - Chandra S
AU  - Muñoz-Couselo E
AU  - Del Vecchio M
AU  - de Melo AC
AU  - Callahan M
AU  - Gogas H
AU  - Dummer R
AU  - Schadendorf D
AU  - Koelblinger P
AU  - Quereux G
AU  - Thomas I
AU  - Yu JX
AU  - Fisher A
AU  - Wang B
AU  - Djidel P
AU  - Chouzy A
AU  - Semaan M
AU  - Chen B
AU  - Cheong AMY
AU  - Tawbi HA
PY  - 2026
JO  - Future oncology (London, England)
DO  - 10.1080/14796694.2026.2721180
UR  - https://doi.org/10.1080/14796694.2026.2721180
ER  -

APA

GV, L., C, G., S, D., PA, A., J, G., AA, T., S, C., E, M., M, D. V., AC, D. M., M, C., H, G., R, D., D, S., P, K., G, Q., I, T., JX, Y., A, F., B, W., P, D., A, C., M, S., B, C., AMY, C., & HA, T. (2026). Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery.. Future oncology (London, England). https://doi.org/10.1080/14796694.2026.2721180

Source records

pubmed · retrieved 2026-09-25T22:51:55.554Z